GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Illumina, Inc. (ILMN) [hlAlert]

Rating:
Outperform
ILMN
up 149.30 %

Illumina, Inc. (ILMN) rated Outperform by Wells Fargo

Posted on: Tuesday,  Sep 10, 2013  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Illumina, Inc. (NASDAQ: ILMN) on 09/10/2013, when the stock price was $81.00. Since
then, Illumina, Inc. has gained 149.31% as of 01/26/2016's recent price of $201.94.
If you would have followed this Wells Fargo's recommendation on ILMN, you would have gained 149.3% of your investment in 868 days.

Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets. It also, develops and commercializes sequencing technologies used to perform a range of analyses, including whole genome re-sequencing, gene expression analysis and small ribonucleic acid (RNA) analysis. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. The Company operates in two business segments: Life Sciences and Diagnostics. On August 1, 2008, the Company acquired Avantome, Inc. The Company?s subsidiary is Solexa, Inc.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2013 8:25 AM Buy
None
81.00
as of 12/13/2013
1 Week up  3.20 %
1 Month up  7.47 %
3 Months up  21.14 %
1 YTD up  26.45 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy